Surgeons Transplanted a Lab-Grown Ear From Patient's Own Cells in Early Clinical Trial
3 JUNE 2022A US medical team said Thursday they had reconstructed a human ear using the patient's own tissue to create a 3D bioimplant, a pioneering procedure they hope can be used to treat people with a rare birth defect.
The surgery was performed as part of an early-stage clinical trial to evaluate the safety and efficacy of the implant for people with microtia, in which the external ear is small and not formed properly.
![www.sciencealert.com](https://www.sciencealert.com/images/2022-06/processed/AnEarShapedPinkThingOnAPetriDish_1024.jpg)
Surgeons Transplanted a Lab-Grown Ear From Patient's Own Cells in Early Clinical Trial
A US medical team said Thursday they had reconstructed a human ear using the patient's own tissue to create a 3D bioimplant, a pioneering procedure they hope can be used to treat people with a rare birth defect.
![www.sciencealert.com](https://www.sciencealert.com/android-icon-192x192.png)
The human outer ear is hardly a vital organ. But this progress in tissue propagation is an encouraging sign of the expanding potential.
One of the benefits of growing replacement tissue from the patient's own DNA is the elimination of anti-rejection drugs, leaving the patient in substantially more robust good health.